Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...

Prolonged conversations with AI chatbots can start to break down the safety guardrails. Here's how to watch for warning signs.

Here's how a quiet hardware revolution is solving the intimacy-surveillance paradox and creating a safe harbor for relationships with AI, using new models and edge AI hardware.

Red light therapy has gone from dermatology clinics to the wellness world, promising everything from younger-looking skin and ...

There is an emerging convergence between atherosclerotic cardiovascular disease and cancer, driven by shared risk factors and overlapping pathophysiologic mechanisms. Traditional factors, such as ...

February is Heart Health Month, and heart disease remains the number one killer of Americans. But improving heart health might be easier than people think. A construction worker’s decision to ignore a ...

PORTLAND, Ore. (KPTV) - February is Heart Health Month, a time to raise awareness about heart disease and its causes, especially in women. Nearly 45% of women age 20 and older are living with some ...

This Breakthrough Therapy Designation is based on results from the PEAK trial, which demonstrated a substantial and highly statistically significant clinical benefit on the primary endpoint of ...

NEW HAVEN, Conn. (WTNH) — In today’s Health Headlines, what women in menopause need to know about the risks and benefits of hormone replacement therapy. Plus, how staying active could prevent or slow ...

For more than a week, Salt Lake City has been pestered by a haze of pollutants that are trapped in cold air at the bottom of the valley. Soon, that’s going to change, according to the National Weather ...

Knoepfler is a professor of cell biology and human anatomy at UC Davis School of Medicine. At a Food and Drug Administration cell and gene therapy (CGT) roundtable last June, most speakers pushed for ...

—A secondary analysis of the Women’s Health Initiative trials assessed cardiovascular risk in postmenopausal women using hormone therapy for vasomotor symptoms. The results emphasize the critical ...